Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach
Authors:
- Simone L. BroerSimone L. Broer
- Jeroen van DisseldorpJeroen van Disseldorp
- Kimiko A. BroezeKimiko A. Broeze
- Madeleine DollemanMadeleine Dolleman
- Brent C. OpmeerBrent C. Opmeer
- Patrick BossuytPatrick Bossuyt
- Marinus J.C. EijkemansMarinus J.C. Eijkemans
- Ben-Willem J. MolBen-Willem J. Mol
- on behalf of the IMPORT study groupOGon behalf of the IMPORT study group
- R.A. AndersonR.A. Anderson
- M. AshrafiM. Ashrafi
Top Cited Papers
Open Access
- 1 January 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction Update
- Vol. 19 (1) , 26-36
Abstract
Although ovarian reserve tests (ORTs) are frequently used prior to IVF treatment for outcome prediction, their added predictive value is unclear. We assessed the added value of ORTs to patient characteristics in the prediction of IVF outcome. An individual patient data (IPD) meta-analysis from published studies was performed. Studies on FSH, anti-Müllerian hormone (AMH) or antral follicle count (AFC) in women undergoing IVF were identified and authors were contacted. Using random intercept logistic regression models, we estimated the added predictive value of ORTs for poor response and ongoing pregnancy after IVF, relative to patient characteristics. We were able to collect 28 study databases, comprising 5705 women undergoing IVF. The area under the receiver-operating characteristic curve (AUC) for female age in predicting poor response was 0.61. AFC and AMH each significantly improved the model fit (P-value P = 0.19) of poor response. In predicting ongoing pregnancy after IVF, age was the best single predictor (AUC 0.57), and none of the ORTs added any value. This IPD meta-analysis demonstrates that AFC and AMH clearly add to age in predicting poor response. As single tests, AFC and AMH both fully cover the prediction of poor ovarian response. In contrast, none of the ORTs add any information to the limited capacity of female age to predict ongoing pregnancy after IVF. The clinical usefulness of ORTs prior to IVF will be limited to the prediction of ovarian response.Keywords
This publication has 62 references indexed in Scilit:
- Anti-Müllerian Hormone Predicts Menopause: A Long-Term Follow-Up Study in Normoovulatory WomenThe Journal of Clinical Endocrinology & Metabolism, 2011
- Individual patient data meta-analysis: a promising approach for evidence synthesis in reproductive medicineHuman Reproduction Update, 2010
- Deep phenotyping to predict live birth outcomes in in vitro fertilizationProceedings of the National Academy of Sciences, 2010
- Individual patient data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicineBMC Medical Research Methodology, 2009
- The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle countFertility and Sterility, 2009
- Age-Specific Levels for Basal Follicle-Stimulating Hormone Assessment of Ovarian FunctionObstetrics & Gynecology, 2007
- Effect of embryo quality on pregnancy outcome following single embryo transfer in women with a diminished egg reserveFertility and Sterility, 2007
- What can the clinician do to improve implantation?Reproductive BioMedicine Online, 2006
- A systematic review of tests predicting ovarian reserve and IVF outcomeHuman Reproduction Update, 2006
- Follicle stimulating hormone as a predictor of ovarian response in women undergoing controlled ovarian hyperstimulation for IVFInternational Journal of Gynecology & Obstetrics, 2005